Clinical Trial

Middle Meningeal Artery Embolization for Chronic Migraine

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
IRB submission never completed, study application withdrawn by IRB due to lack of response from PI
Summary
The main goal of this study is to find out how well middle meningeal artery coil embolization works for patients with recurrent chronic migraines that are not resolved with medication.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-06-30; most recent amendment 2026-02-04.
Status change: Not Yet Recruiting → Withdrawn 2026-02-04
Trial Details
NCT Number NCT07044648
Lead Sponsor Wake Forest University Health Sciences
Conditions Migraine
Start Date 2026-02
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-06